No difference in prevalence of pituitary imaging abnormalities in men with secondary hypogonadism presenting with decreased bone mineral density versus erectile dysfunction

Hans K. Ghayee, Polina Kalyanova, Vishal Patel, Ugis Gruntmanis

Research output: Contribution to journalArticle

Abstract

The aim of this study was to compare the prevalence of pituitary imaging abnormalities in men presenting with decreased bone mineral density (BMD) versus erectile dysfunction and found to have secondary hypogonadism. Medical records of all men referred for erectile dysfunction or decreased BMD and found to have secondary hypogonadism and who had pituitary magnetic resonance imaging (MRI) performed were reviewed. The records of 40 men seen in Endocrine Clinic of the Dallas Veterans Affairs Medical Center were evaluated. Twentyfive men were referred for erectile dysfunction and 15 were referred for decreased BMD. There were no differences between the 2 groups by age, morning pooled testosterone, luteinizing hormone, prolactin, thyroid stimulating hormone, and free thyroxine. Patients with decreased BMD and secondary hypogonadism were found to have lower weight with P value that was statistically significant. MRI abnormalities were found in 16% (4 of 25) of patients with secondary hypogonadism and erectile dysfunction versus 13.3% (2 of 15) of those with decreased BMD and secondary hypogonadism (P = NS). When groups are pooled, patients with pituitary abnormalities on imaging had elevated prolactin (P < 0.006), but no difference in testosterone levels. It can be concluded that in our study population, men who present with decreased BMD or erectile dysfunction and are found to have secondary hypogonadism have similar rate of pituitary abnormalities on MRI.

Original languageEnglish (US)
Pages (from-to)126-129
Number of pages4
JournalEndocrinologist
Volume18
Issue number3
DOIs
StatePublished - May 2008

Fingerprint

Hypogonadism
Erectile Dysfunction
Bone Density
Magnetic Resonance Imaging
Prolactin
Testosterone
Veterans
Thyrotropin
Luteinizing Hormone
Thyroxine
Medical Records
Age Groups
Weights and Measures
Population

Keywords

  • Decreased bone mineral density
  • Erectile dysfunction
  • Hypogonadism
  • Pituitary imaging

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

No difference in prevalence of pituitary imaging abnormalities in men with secondary hypogonadism presenting with decreased bone mineral density versus erectile dysfunction. / Ghayee, Hans K.; Kalyanova, Polina; Patel, Vishal; Gruntmanis, Ugis.

In: Endocrinologist, Vol. 18, No. 3, 05.2008, p. 126-129.

Research output: Contribution to journalArticle

@article{3ea2506fb661481190e3a525135b46c8,
title = "No difference in prevalence of pituitary imaging abnormalities in men with secondary hypogonadism presenting with decreased bone mineral density versus erectile dysfunction",
abstract = "The aim of this study was to compare the prevalence of pituitary imaging abnormalities in men presenting with decreased bone mineral density (BMD) versus erectile dysfunction and found to have secondary hypogonadism. Medical records of all men referred for erectile dysfunction or decreased BMD and found to have secondary hypogonadism and who had pituitary magnetic resonance imaging (MRI) performed were reviewed. The records of 40 men seen in Endocrine Clinic of the Dallas Veterans Affairs Medical Center were evaluated. Twentyfive men were referred for erectile dysfunction and 15 were referred for decreased BMD. There were no differences between the 2 groups by age, morning pooled testosterone, luteinizing hormone, prolactin, thyroid stimulating hormone, and free thyroxine. Patients with decreased BMD and secondary hypogonadism were found to have lower weight with P value that was statistically significant. MRI abnormalities were found in 16{\%} (4 of 25) of patients with secondary hypogonadism and erectile dysfunction versus 13.3{\%} (2 of 15) of those with decreased BMD and secondary hypogonadism (P = NS). When groups are pooled, patients with pituitary abnormalities on imaging had elevated prolactin (P < 0.006), but no difference in testosterone levels. It can be concluded that in our study population, men who present with decreased BMD or erectile dysfunction and are found to have secondary hypogonadism have similar rate of pituitary abnormalities on MRI.",
keywords = "Decreased bone mineral density, Erectile dysfunction, Hypogonadism, Pituitary imaging",
author = "Ghayee, {Hans K.} and Polina Kalyanova and Vishal Patel and Ugis Gruntmanis",
year = "2008",
month = "5",
doi = "10.1097/TEN.0b013e31816b9076",
language = "English (US)",
volume = "18",
pages = "126--129",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - No difference in prevalence of pituitary imaging abnormalities in men with secondary hypogonadism presenting with decreased bone mineral density versus erectile dysfunction

AU - Ghayee, Hans K.

AU - Kalyanova, Polina

AU - Patel, Vishal

AU - Gruntmanis, Ugis

PY - 2008/5

Y1 - 2008/5

N2 - The aim of this study was to compare the prevalence of pituitary imaging abnormalities in men presenting with decreased bone mineral density (BMD) versus erectile dysfunction and found to have secondary hypogonadism. Medical records of all men referred for erectile dysfunction or decreased BMD and found to have secondary hypogonadism and who had pituitary magnetic resonance imaging (MRI) performed were reviewed. The records of 40 men seen in Endocrine Clinic of the Dallas Veterans Affairs Medical Center were evaluated. Twentyfive men were referred for erectile dysfunction and 15 were referred for decreased BMD. There were no differences between the 2 groups by age, morning pooled testosterone, luteinizing hormone, prolactin, thyroid stimulating hormone, and free thyroxine. Patients with decreased BMD and secondary hypogonadism were found to have lower weight with P value that was statistically significant. MRI abnormalities were found in 16% (4 of 25) of patients with secondary hypogonadism and erectile dysfunction versus 13.3% (2 of 15) of those with decreased BMD and secondary hypogonadism (P = NS). When groups are pooled, patients with pituitary abnormalities on imaging had elevated prolactin (P < 0.006), but no difference in testosterone levels. It can be concluded that in our study population, men who present with decreased BMD or erectile dysfunction and are found to have secondary hypogonadism have similar rate of pituitary abnormalities on MRI.

AB - The aim of this study was to compare the prevalence of pituitary imaging abnormalities in men presenting with decreased bone mineral density (BMD) versus erectile dysfunction and found to have secondary hypogonadism. Medical records of all men referred for erectile dysfunction or decreased BMD and found to have secondary hypogonadism and who had pituitary magnetic resonance imaging (MRI) performed were reviewed. The records of 40 men seen in Endocrine Clinic of the Dallas Veterans Affairs Medical Center were evaluated. Twentyfive men were referred for erectile dysfunction and 15 were referred for decreased BMD. There were no differences between the 2 groups by age, morning pooled testosterone, luteinizing hormone, prolactin, thyroid stimulating hormone, and free thyroxine. Patients with decreased BMD and secondary hypogonadism were found to have lower weight with P value that was statistically significant. MRI abnormalities were found in 16% (4 of 25) of patients with secondary hypogonadism and erectile dysfunction versus 13.3% (2 of 15) of those with decreased BMD and secondary hypogonadism (P = NS). When groups are pooled, patients with pituitary abnormalities on imaging had elevated prolactin (P < 0.006), but no difference in testosterone levels. It can be concluded that in our study population, men who present with decreased BMD or erectile dysfunction and are found to have secondary hypogonadism have similar rate of pituitary abnormalities on MRI.

KW - Decreased bone mineral density

KW - Erectile dysfunction

KW - Hypogonadism

KW - Pituitary imaging

UR - http://www.scopus.com/inward/record.url?scp=67650758020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650758020&partnerID=8YFLogxK

U2 - 10.1097/TEN.0b013e31816b9076

DO - 10.1097/TEN.0b013e31816b9076

M3 - Article

AN - SCOPUS:67650758020

VL - 18

SP - 126

EP - 129

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 3

ER -